0001640455-22-000017.txt : 20220203 0001640455-22-000017.hdr.sgml : 20220203 20220203193722 ACCESSION NUMBER: 0001640455-22-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURRAY RICHARD /CA/ CENTRAL INDEX KEY: 0001242935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 22590396 MAIL ADDRESS: STREET 1: 22643 WOODRIDGE CT CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_164393502683270.xml FORM 4 X0306 4 2022-02-01 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001242935 MURRAY RICHARD /CA/ C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 1 1 0 0 CEO and President Common Stock 2022-02-01 4 A 0 87500 0 A 273077 D Stock Option (Right to Buy) 7.56 2022-02-01 4 A 0 175000 0 A 2032-02-01 Common Stock 175000.0 175000 D The option will vest quarterly in 16 equal installments following January 1, 2022. /s/ Kim C. Drapkin, Attorney-in-Fact 2022-02-03